Affiliation: Celgene Corporation
- Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy womenClaudia Kasserra
Schering Plough, Merck and Co, Inc, Kenilworth, New Jersey, USA
Clin Ther 33:1503-14. 2011....
- Effect of vicriviroc on the QT/corrected QT interval and central nervous system in healthy subjectsEdward O'Mara
Merck and Co, Kenilworth, NJ 07033, USA
Antimicrob Agents Chemother 54:2448-54. 2010....
- Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trialsClaudia Kasserra
Schering Plough, Merck and Co, Inc, Kenilworth, New Jersey 07033, USA
Clin Pharmacokinet 50:267-80. 2011..The aim of this set of studies was to determine what, if any, dose adjustments or monitoring would be required to use vicriviroc in regimens containing the most common antiretroviral agents...
- Renal insufficiency has no effect on the pharmacokinetics of vicriviroc in a ritonavir-containing regimenClaudia Kasserra
Schering Plough Research Institute, Kenilworth, New Jersey 07033, USA
Clin Pharmacokinet 49:397-406. 2010..The present study therefore examined the impact of renal insufficiency on the pharmacokinetics and safety of vicriviroc alone and in the presence of ritonavir, a strong CYP3A4 inhibitor...